A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has ...

BEIRUT — Hezbollah announced that Hashem Safieddine, one of its top officials who had been widely expected to be the group’s ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

While it’s a win for Pfizer over GSK and its RSV vaccine Arexvy, which is approved for those 50 and older, it’s difficult to ...

Each year, World Polio Day (Oct. 24) and World Pneumonia Day (Nov. 12) are reminders of the global efforts toward a ...

The World Health Organization (WHO) announced on Wednesday that the final phase of the polio vaccination campaign in northern ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Dairy and poultry farmers in Mower County can get free, seasonal influenza (flu) shots on their farm, thanks to a new public ...

Air raid sirens echoed across Tel Aviv on Wednesday as United States Secretary of State Antony Blinken prepared to end a ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.